The CFF/NIH R01-Unfunded Award supports cystic fibrosis investigators with favorably reviewed, unfunded proposals, funding work to address reviewer concerns and strengthen resubmission to a governmental agency.
Funder: Cystic Fibrosis Foundation
Due Dates: November 30, 2026 (full application; rolling until then)
Funding Amounts: Up to $125,000 in direct costs for one year
Summary: Bridge funding helps investigators strengthen favorably reviewed, unfunded cystic fibrosis research for resubmission to a governmental funding agency.
Key Information: The original proposal must be an NIH R01 or equivalent governmental application that can be resubmitted within one year of the award.
The Cystic Fibrosis Foundation offers this award to keep meritorious cystic fibrosis (CF) research moving when an NIH R01 or equivalent governmental application has been favorably reviewed but cannot be funded. The one-year bridge award supports work that develops preliminary data, addresses reviewers’ concerns, and improves the proposal’s prospects when resubmitted to the original funding agency.
The Foundation prioritizes research that could advance prevention or treatment or improve understanding of CF disease mechanisms and pathophysiology. Areas of interest include the effects of CFTR modulators, approaches for people who do not benefit from them, difficult-to-treat infections, and CF-related complications.